Show simple item record

dc.contributor.authorSelle, Martina
dc.contributor.authorHertlein, Tobias
dc.contributor.authorOesterreich, Babett
dc.contributor.authorKlemm, Theresa
dc.contributor.authorKloppot, Peggy
dc.contributor.authorMüller, Elke
dc.contributor.authorEhricht, Ralf
dc.contributor.authorStentzel, Sebastian
dc.contributor.authorBröker, Barbara M
dc.contributor.authorEngelmann, Susanne
dc.contributor.authorOhlsen, Knut
dc.date.accessioned2016-05-13T14:08:25Zen
dc.date.available2016-05-13T14:08:25Zen
dc.date.issued2016en
dc.identifier.citationGlobal antibody response to Staphylococcus aureus live-cell vaccination. 2016, 6:24754 Sci Repen
dc.identifier.issn2045-2322en
dc.identifier.pmid27103319en
dc.identifier.doi10.1038/srep24754en
dc.identifier.urihttp://hdl.handle.net/10033/609272en
dc.description.abstractThe pathogen Staphylococcus aureus causes a broad range of severe diseases and is feared for its ability to rapidly develop resistance to antibiotic substances. The increasing number of highly resistant S. aureus infections has accelerated the search for alternative treatment options to close the widening gap in anti-S. aureus therapy. This study analyses the humoral immune response to vaccination of Balb/c mice with sublethal doses of live S. aureus. The elicited antibody pattern in the sera of intravenously and intramuscularly vaccinated mice was determined using of a recently developed protein array. We observed a specific antibody response against a broad set of S. aureus antigens which was stronger following i.v. than i.m. vaccination. Intravenous but not intramuscular vaccination protected mice against an intramuscular challenge infection with a high bacterial dose. Vaccine protection was correlated with the strength of the anti-S. aureus antibody response. This study identified novel vaccine candidates by using protein microarrays as an effective tool and showed that successful vaccination against S. aureus relies on the optimal route of administration.
dc.language.isoenen
dc.titleGlobal antibody response to Staphylococcus aureus live-cell vaccination.en
dc.typeArticleen
dc.contributor.departmentHelmholtz Centre for infection research, Inhoffenstr. 7, 38124 Braunschweig, Germany.en
dc.identifier.journalScientific reportsen
refterms.dateFOA2018-06-12T18:09:40Z
html.description.abstractThe pathogen Staphylococcus aureus causes a broad range of severe diseases and is feared for its ability to rapidly develop resistance to antibiotic substances. The increasing number of highly resistant S. aureus infections has accelerated the search for alternative treatment options to close the widening gap in anti-S. aureus therapy. This study analyses the humoral immune response to vaccination of Balb/c mice with sublethal doses of live S. aureus. The elicited antibody pattern in the sera of intravenously and intramuscularly vaccinated mice was determined using of a recently developed protein array. We observed a specific antibody response against a broad set of S. aureus antigens which was stronger following i.v. than i.m. vaccination. Intravenous but not intramuscular vaccination protected mice against an intramuscular challenge infection with a high bacterial dose. Vaccine protection was correlated with the strength of the anti-S. aureus antibody response. This study identified novel vaccine candidates by using protein microarrays as an effective tool and showed that successful vaccination against S. aureus relies on the optimal route of administration.


Files in this item

Thumbnail
Name:
Selle et al.pdf
Size:
1.354Mb
Format:
PDF
Description:
Open Access article

This item appears in the following Collection(s)

Show simple item record